17-50199888-GT-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000088.4(COL1A1):c.162del(p.Lys54AsnfsTer20) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
COL1A1
NM_000088.4 frameshift
NM_000088.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.19
Genes affected
COL1A1 (HGNC:2197): (collagen type I alpha 1 chain) This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-50199888-GT-G is Pathogenic according to our data. Variant chr17-50199888-GT-G is described in ClinVar as [Pathogenic]. Clinvar id is 429812.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL1A1 | NM_000088.4 | c.162del | p.Lys54AsnfsTer20 | frameshift_variant | 2/51 | ENST00000225964.10 | NP_000079.2 | |
COL1A1 | XM_011524341.2 | c.162del | p.Lys54AsnfsTer20 | frameshift_variant | 2/48 | XP_011522643.1 | ||
COL1A1 | XM_005257058.5 | c.162del | p.Lys54AsnfsTer20 | frameshift_variant | 2/49 | XP_005257115.2 | ||
COL1A1 | XM_005257059.5 | c.162del | p.Lys54AsnfsTer20 | frameshift_variant | 2/38 | XP_005257116.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL1A1 | ENST00000225964.10 | c.162del | p.Lys54AsnfsTer20 | frameshift_variant | 2/51 | 1 | NM_000088.4 | ENSP00000225964 | P1 | |
ENST00000509943.2 | n.16del | non_coding_transcript_exon_variant | 1/7 | 3 | ||||||
COL1A1 | ENST00000507689.1 | c.216del | p.Lys72AsnfsTer20 | frameshift_variant | 1/4 | 2 | ENSP00000460459 | |||
COL1A1 | ENST00000474644.1 | n.281del | non_coding_transcript_exon_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 35
GnomAD4 exome
Cov.:
35
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 15, 2015 | The c.162delA deletion in the COL1A1 gene has not been reported previously as a pathogenic variant nor as a benign polymorphism, to our knowledge. The c.162delA variant causes a frameshift starting with codon Lysine 54, changes this amino acid to a Asparagine residue, and creates a premature Stop codon at position 20 the new reading frame, denoted p.Lys54AsnfsX20. This deletion is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.162delA variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.162delA as a pathogenic variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at